克隆浆细胞能量代谢转录组过度表达与多发性骨髓瘤发病机制及患者结局相关
研究利用MMRF CoMMpass数据集中新诊断多发性骨髓瘤(NDMM)患者克隆浆细胞,对糖酵解和氧化磷酸化通路相关基因按FPKM高于中位数计1分构建能量代谢分子特征(EMMS)评分(0–12分)。EMMS评分与更差的无进展生存(PFS)和总生存(OS)独立相关,且MM患者克隆浆细胞EMMS评分高于MGUS患者,功能上MM克隆浆细胞线粒体和糖酵解来源ATP生成速率更高。
要点
- EMMS评分由糖酵解和氧化磷酸化通路基因FPKM高于中位数各计1分构成,范围0–12分。
- EMMS评分与NDMM患者更差的PFS和OS独立相关。
- MM患者克隆浆细胞EMMS评分高于MGUS患者,且线粒体和糖酵解来源ATP生成速率更高。
核心结论
- 克隆浆细胞内能量代谢对MM发病机制和患者结局有影响。
- 未来应探索利用克隆浆细胞能量产生代谢通路用于MM诊断和治疗。
研究设计与样本
- 基于MMRF CoMMpass数据集中新诊断多发性骨髓瘤(NDMM)患者的克隆浆细胞进行基因表达评估。
- 对糖酵解和氧化磷酸化通路基因按FPKM高于中位数计1分,构建EMMS评分(最低0分,最高12分)。
主要发现
- EMMS评分与NDMM患者更差的无进展生存(PFS)和总生存(OS)独立相关。
- MM患者克隆浆细胞EMMS评分高于MGUS患者。
- MM患者克隆浆细胞线粒体和糖酵解来源ATP生成速率高于MGUS患者克隆浆细胞。
关键数值与推荐
- EMMS评分:每个基因FPKM高于中位数计1分,糖酵解和氧化磷酸化通路基因集最低0分、最高12分。
- EMMS评分与更差PFS和OS独立相关。
- MM患者克隆浆细胞EMMS评分高于MGUS患者。
- MM患者克隆浆细胞线粒体和糖酵解来源ATP生成速率高于MGUS患者克隆浆细胞。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Altered energy metabolism and changes in glycolytic and oxidative phosphorylation pathways are hallmarks of all cancer cells. The expression of select genes associated with the production of various enzymes and proteins involved in glycolysis and oxidative phosphorylation were assessed in the clonal plasma cells derived from patients with newly diagnosed multiple myeloma (NDMM) enrolled in the Multiple Myeloma Research Foundation (MMRF) CoMMpass data set. A scoring system consisting of assigning a point for every gene where their fragments per kilobase of transcript per million (FPKM) was above the median yielded a minimum of 0 and a maximum of 12 for the set of genes in the glycolytic and oxidative phosphorylation pathways to create a total energy metabolism molecular signature (EMMS) score. This EMMS score was independently associated with worse progression free survival (PFS) and overall survival (OS) outcomes of patients with NDMM. A higher EMMS score was more likely to be present in clonal plasma cells derived from Multiple myeloma (MM) patients than those from patients with monoclonal gammopathy of undetermined significance (MGUS). This was functionally confirmed by the clonal plasma cells from MM patients having a higher rate of mitochondrial and glycolysis-derived ATP formation than clonal plasma cells from MGUS patients. Thus, this study provides evidence for the effect of energy metabolism within clonal plasma cells on pathogenesis and outcomes of patients with MM. Exploiting the energy-producing metabolic pathways within clonal plasma cells for diagnostic and therapeutic purposes in MM should be explored in the future.
引用
- Evans LA, Anderson EA, Jessen E, et al. Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma. Am J Hematol. 2022. PMID: 35481878. doi:10.1002/ajh.26577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。